BioCentury | Aug 4, 2020
Politics, Policy & Law

China doubling size of centralized procurement program

...and hypercholesterolemia drug Livalo pitavastatin from Kowa Co. Ltd. and Alzheimer’s disease (AD) therapy Namenda memantine...
BioCentury | Jun 28, 2019
Politics & Policy

‘Product hopping’ under fire in Senate bill

...When Allergan withdrew Alzheimer's disease drug Namenda memantine from the market so physicians would prescribe a...
...encourage patients to switch to the follow-on. Cornyn said the swap of twice-daily for once-daily Namenda...
...not respond to a request for comment on the Namenda. Elizabeth S. Eaton, Staff Writer Namenda XR, memantine Allergan...
BioCentury | Apr 26, 2019
Emerging Company Profile

ProNeurogen: Angiotensin peptides for vascular cognitive impairment

...clinical trials have evaluated AD drugs, such as cholinesterase inhibitor donepezil and NMDA receptor antagonist memantine...
BioCentury | Feb 1, 2019
Financial News

Drug delivery company Lyndra raises $55M series B

...compounds from partner companies. Lyndra has LYN-057, a capsule formulation of the NMDA receptor antagonist memantine...
BioCentury | Jan 29, 2019
Financial News

Drug delivery company Lyndra raises $55M series B

...compounds from partner companies. Lyndra has LYN-057, a capsule formulation of the NMDA receptor antagonist memantine...
BioCentury | Jan 5, 2018
Company News

Allergan cutting jobs ahead of Restasis competition

...disease drug Namenda XR memantine. Allergan plc (NYSE:AGN), Dublin, Ireland Business: Ophthalmic Jaime De Leon Aczone Atrisone cyclosporine Dapsone topical gel Delzicol memantine mesalamine Namenda...
BioCentury | Jan 4, 2018
Company News

Allergan cutting jobs ahead of Restasis competition

...include gastrointestinal drug Delzicol mesalamine, topical acne treatment Aczone and Alzheimer disease drug Namenda XR memantine. Jaime...
BioCentury | Dec 5, 2017
Distillery Therapeutics

Neurology

...treat autism caused by MEF2C haploinsufficiency. In an MEF2C-haploinsufficient mouse model of autism, NitroSynapsin, a memantine-based...
...with Panorama Research Inc. include studies of NitroSynapsin to treat autism. The generic NMDA antagonist memantine...
BioCentury | Nov 17, 2017
Preclinical News

Memantine-based NMDA receptor antagonist could help treat autism

...research is patented in partnership with Panorama Research Inc. (Sunnyvale, Calif.). NitroSynapsin is based on memantine...
BioCentury | Oct 28, 2017
Strategy

Biogen doubles down

...for decreased profits in Japan. He noted AD drugs such as Aricept donepezil and Namenda memantine...
...10%. In Japan, Eisai and Pfizer Inc. co-promote Aricept, and Daiichi Sankyo Co. Ltd. markets Namenda...
Items per page:
1 - 10 of 292